Want to see IN:VIYASH full AI Analyst Report?
VIYASH Stock Chart & Stats
₹210.65
-₹3.94(-2.00%)
At close: 4:00 PM EST
₹210.65
-₹3.94(-2.00%)
Day’s Range― - ―
52-Week Range₹169.30 - ₹297.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)547.47K
Market Cap
₹115.21B
Enterprise Value₹85.83K
Total Cash (Recent Filing)₹2.70B
Total Debt (Recent Filing)₹4.90B
Price to Earnings (P/E)61.8
Beta1.23
Next Earnings
Nov 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.25
Shares Outstanding439,907,600
10 Day Avg. Volume1,432,490
30 Day Avg. Volume547,468
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.72
Price to Sales (P/S)2.32
P/FCF Ratio61.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.55
Revenue Forecast (FY)₹38.99B
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability ReboundThe sharp revenue acceleration and improved operating margins indicate stronger business scale and earnings potential. If sustained, better operating leverage can support durable profitability, although the recent rebound still requires further validation.
Improved Balance SheetSubstantially lower leverage and expanding equity strengthen financial resilience. A lighter debt burden can reduce funding pressure, preserve flexibility for operations or investment, and make the company better positioned to withstand earnings volatility.
Improving Cash GenerationThe return to positive and growing free cash flow is an important improvement in financial quality. Sustained cash generation would provide internally funded support for investment, debt management, and business expansion without relying as heavily on external capital.
Bears Say
Volatile Profitability Track RecordRecent profitability remains unproven across the cycle because the business experienced losses and negative EBIT margins shortly before the rebound. This history raises uncertainty about cost stability and whether current earnings can persist through weaker operating conditions.
Weak Cash ConversionEarnings are not yet translating fully into cash, limiting the quality and flexibility of reported profits. Continued weak conversion could constrain reinvestment and shareholder returns, while also increasing sensitivity to working-capital movements or capital spending.
Low Operating Cash Flow IntensityLow operating cash flow relative to revenue suggests the enlarged business has not yet established strong cash economics. If this persists, growth may require more working capital or investment funding, reducing the durability of margins and free cash flow improvements.
Viyash Scientific News
VIYASH FAQ
What was Viyash Scientific Limited’s price range in the past 12 months?
Viyash Scientific Limited lowest stock price was ₹169.30 and its highest was ₹297.90 in the past 12 months.
What is Viyash Scientific Limited’s market cap?
Viyash Scientific Limited’s market cap is ₹115.21B.
When is Viyash Scientific Limited’s upcoming earnings report date?
Viyash Scientific Limited’s upcoming earnings report date is Nov 14, 2026 which is in 72 days.
How were Viyash Scientific Limited’s earnings last quarter?
Viyash Scientific Limited released its earnings results on Aug 11, 2026. The company reported ₹1.49 earnings per share for the quarter, missing the consensus estimate of ₹2 by -₹0.51.
Is Viyash Scientific Limited overvalued?
According to Wall Street analysts Viyash Scientific Limited’s price is currently Overvalued.
Does Viyash Scientific Limited pay dividends?
Viyash Scientific Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Viyash Scientific Limited dividends here
What is Viyash Scientific Limited’s EPS estimate?
Viyash Scientific Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Viyash Scientific Limited have?
Viyash Scientific Limited has 439,907,600 shares outstanding.
What happened to Viyash Scientific Limited’s price movement after its last earnings report?
Viyash Scientific Limited reported an EPS of ₹1.49 in its last earnings report, missing expectations of ₹2. Following the earnings report the stock price went down -4.511%.
Which hedge fund is a major shareholder of Viyash Scientific Limited?
Currently, no hedge funds are holding shares in IN:VIYASH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Viyash Scientific Limited
Viyash Scientific Limited is a global veterinary healthcare company with operations spanning Europe, Asia, and other international markets. It specializes in developing and supplying finished dosage forms for a range of therapeutic applications, including nutritional support, pain relief, parasite control, antibiotic treatments, and gut health solutions. These products cater to various animals like livestock, poultry, and domestic pets. Additionally, the company extends its expertise through analytical testing and specialized veterinary formulation services. Originally established as Sequent Scientific Limited, the company officially adopted the name Viyash Scientific Limited in January 2026. Founded in 1985, its corporate headquarters are situated in Hyderabad, India. Currently, Viyash Scientific Limited functions as a subsidiary of CA Harbor Investments.
Technical Analysis
Akums Drugs and Pharmaceuticals Limited
―
Alembic Pharmaceuticals Limited
―
Caplin Point Laboratories Limited
―
Glenmark Life Sciences Limited
―
Strides Pharma Science Ltd
―